GAMBARO, Giovanni
 Distribuzione geografica
Continente #
NA - Nord America 17.743
EU - Europa 14.971
AS - Asia 13.647
SA - Sud America 2.698
Continente sconosciuto - Info sul continente non disponibili 629
AF - Africa 399
OC - Oceania 39
Totale 50.126
Nazione #
US - Stati Uniti d'America 17.410
RU - Federazione Russa 6.418
SG - Singapore 5.903
CN - Cina 3.355
GB - Regno Unito 2.125
BR - Brasile 2.075
IT - Italia 1.513
VN - Vietnam 1.321
HK - Hong Kong 1.172
FR - Francia 1.140
IE - Irlanda 1.087
SE - Svezia 721
DE - Germania 682
KR - Corea 510
FI - Finlandia 481
UA - Ucraina 359
BD - Bangladesh 293
AR - Argentina 247
IN - India 207
CA - Canada 159
ID - Indonesia 130
JP - Giappone 109
EC - Ecuador 104
IQ - Iraq 90
TR - Turchia 87
ZA - Sudafrica 83
NL - Olanda 78
MX - Messico 77
PK - Pakistan 75
NG - Nigeria 73
CO - Colombia 72
VE - Venezuela 60
ES - Italia 57
AT - Austria 47
PH - Filippine 47
PL - Polonia 47
UZ - Uzbekistan 47
BE - Belgio 43
CL - Cile 43
MA - Marocco 37
PY - Paraguay 36
BJ - Benin 35
TG - Togo 35
AU - Australia 30
SA - Arabia Saudita 30
TN - Tunisia 29
IL - Israele 27
MY - Malesia 26
EG - Egitto 25
AZ - Azerbaigian 24
GR - Grecia 21
KZ - Kazakistan 21
PE - Perù 21
UY - Uruguay 21
DZ - Algeria 20
JO - Giordania 20
AE - Emirati Arabi Uniti 19
KE - Kenya 19
BO - Bolivia 17
CH - Svizzera 17
TH - Thailandia 17
JM - Giamaica 16
RO - Romania 15
CR - Costa Rica 13
CZ - Repubblica Ceca 13
NP - Nepal 12
GT - Guatemala 11
HN - Honduras 11
IR - Iran 11
KG - Kirghizistan 11
LT - Lituania 11
LB - Libano 10
NO - Norvegia 10
PS - Palestinian Territory 10
BG - Bulgaria 9
OM - Oman 9
SK - Slovacchia (Repubblica Slovacca) 9
AL - Albania 8
BH - Bahrain 7
DO - Repubblica Dominicana 7
HR - Croazia 7
KW - Kuwait 7
RS - Serbia 7
SN - Senegal 7
TW - Taiwan 7
XK - ???statistics.table.value.countryCode.XK??? 7
AO - Angola 6
BA - Bosnia-Erzegovina 6
BB - Barbados 6
BY - Bielorussia 6
DK - Danimarca 6
GE - Georgia 6
HU - Ungheria 5
NZ - Nuova Zelanda 5
SV - El Salvador 5
TT - Trinidad e Tobago 5
AM - Armenia 4
EE - Estonia 4
EU - Europa 4
LA - Repubblica Popolare Democratica del Laos 4
Totale 49.411
Città #
Singapore 3.023
Ashburn 2.231
Jacksonville 2.019
San Jose 1.813
Moscow 1.779
Southend 1.757
Chandler 1.325
Dallas 1.307
Hong Kong 1.159
Dublin 1.083
Woodbridge 754
The Dalles 752
Verona 656
Beijing 571
Houston 489
Council Bluffs 479
Ho Chi Minh City 474
Princeton 418
Lawrence 417
Ann Arbor 405
Wilmington 371
New York 301
Hanoi 279
Los Angeles 279
Buffalo 222
Jinan 221
São Paulo 183
Redondo Beach 181
Nanjing 177
Shenyang 152
Columbus 145
Sindelfingen 136
Santa Clara 132
Tianjin 128
Hebei 113
Milan 104
Tokyo 100
Seattle 98
Helsinki 97
Redmond 93
London 79
Guangzhou 76
Changsha 74
Nanchang 73
Zhengzhou 71
Abuja 68
Munich 65
Rio de Janeiro 65
Boardman 62
Ningbo 62
Haikou 60
Norwalk 58
Taizhou 53
Da Nang 52
Montreal 51
Orem 51
Chicago 50
Frankfurt am Main 49
Taiyuan 47
San Francisco 46
Brooklyn 45
Nuremberg 45
Jakarta 44
Brussels 43
Jiaxing 43
Amsterdam 42
Redwood City 42
Tashkent 42
Haiphong 40
Hangzhou 40
Baghdad 39
Chennai 38
Fairfield 38
Warsaw 38
Belo Horizonte 37
Brasília 37
Turku 36
Cotonou 35
Lomé 35
Quito 35
Toronto 35
Shanghai 33
Johannesburg 32
Rome 32
Biên Hòa 30
Bologna 30
Denver 30
Phoenix 30
Porto Alegre 30
Curitiba 29
Hải Dương 29
Atlanta 28
Lanzhou 28
Lancaster 27
Stockholm 27
Guayaquil 26
Mexico City 26
Seoul 26
Campinas 25
Dong Ket 25
Totale 29.007
Nome #
Common Variants Associated to Type 2 Diabetes in the Italian Population 495
Proteomic Analysis of Urinary Microvesicles and Exosomes in Medullary Sponge Kidney Disease and Autosomal Dominant Polycystic Kidney Disease. 293
DISREGOLAZIONE DELLA BIOSINTESI E DEL METABOLISMO DEI PROTEOGLICANI/GLICOSAMINOGLICANI NEI SOGGETTI UREMICI: UNO STUDIO DI GENOMICA FUNZIONALE 260
Eparanasi: un nuovo biomarker di fibrosi e un potenziale target farmacologico per ridurre la progressione del danno renale cronico 259
Placche di Randall e calcolosi ossalo-calcica idiopatica: quale ruolo e quale futuro? 256
A rare variant in APOC3 is associated with plasma triglyceride and VLDL levels in Europeans. 239
Genome-wide association studies identify genetic loci associated with albuminuria in diabetes. 212
Age dependence of within-subject biological variation of nine common clinical chemistry analytes 211
A new mechanism of action of sulodexide in diabetic nephropathy: inhibits heparanase-1 and prevents FIG-2-induced renal epithelial-mesenchymal transition. 202
Prevalence of CKD in northeastern Italy: results of the INCIPE study and comparison with NHANES. 197
Comparison of serum creatinine and cystatin C for early diagnosis of contrast-induced nephropathy after coronary angiography and interventions. 197
[Abnormalities in the erythrocyte membrane transport of oxalate in calcium oxalate lithogenesis]. 190
Anaemia in diabetic renal failure: is there a role for early erythropoietin treatment in preventing cardiovascular mortality? 189
A critical evaluation of the urinary inhibiting activity in idiopathic calcium oxalate nephrolithiasis. 187
mTOR inhibitors and renal allograft: Yin and Yang. 185
[Physical, chemical and morphological urine examination guidelines for the Analytical Phase from the Intersociety Urinalysis Group] 185
A genome-wide association study of anorexia nervosa suggests a risk locus implicated in dysregulated leptin signaling 185
Early creatinine shifts predict contrast-induced nephropathy and persistent renal damage after angiography. 184
The relationship between calcium kidney stones, arterial stiffness and bone density: unraveling the stone-bone-vessel liaison 183
Specific heparanase inhibition reverses glucose-induced mesothelial-to-mesenchymal transition. 182
Comparative transcriptome analysis of peripheral blood mononuclear cells in renal transplant recipients in everolimus- and tacrolimus-based immunosuppressive therapy 181
La qualità della vita nell’anziano in dialisi [Quality of life of the elderly patient on dialysis]. 180
Everolimus-induced epithelial to mesenchymal transition (EMT) in bronchial/pulmonary cells: when the dosage does matter in transplantation 180
An unusual association of contralateral congenital small kidney, reduced renal function and hyperparathyroidism in sponge kidney patients: on the track of the molecular basis. 179
Proteomic-based research strategy identified laminin subunit alpha 2 as a potential urinary-specific biomarker for the medullary sponge kidney disease. 179
Advantages of Using a Web-based Digital Platform for Kidney Preimplantation Biopsies 178
Metabolic Syndrome, Cardiovascular Disease, and Risk for Chronic Kidney Disease in an Italian Cohort: Analysis of the INCIPE Study. 178
A genome-wide association study of anorexia nervosa 176
Familial clustering of medullary sponge kidney is autosomal dominant with reduced penetrance and variable expressivity. 174
Placche di Randal e calcolosi ossalocalcica idiopatica: quale ruolo e quale futuro? 172
Donor-transmitted cancer in kidney transplant recipients: a systematic review 171
Detection of a large deletion in the P-selectin (SELP) gene 170
In vitro effects of interleukin (IL)-1 beta inhibition on the epithelial-to-mesenchymal transition (EMT) of renal tubular and hepatic stellate cells. 170
[Dent's disease: hereditary nephrolithiasis related to defective tubular endocytosis processes] 168
Does Randall’s plaque represent a necessary condition in the pathogenesis of the idiopathic calcium oxalate stones? 167
High chronic nephropathy detection yield in CKD subjects identified by the combination of albuminuria and estimated GFR. 167
[Role of Tamm-Horsfall mucoprotein in calcium oxalate lithogenesis]. 167
Everolimus-induced epithelial to mesenchymal transition in immortalized human renal proximal tubular epithelial cells: key role of heparanase. 165
Arterial stiffness and cardiovascular risk in patients with nephrolithiasis: a 10-year prospective study 164
GDNF gene Variants Associated with Medullary Sponge Kidney. Distinguish a Specific Clinical Phenotype. 164
A Delphi consensus panel on nutritional therapy in chronic kidney disease 164
A validated model of disease progression in IgA nephropathy. 163
[In search of renal stem cells] 163
Sulodexide and glycosaminoglycans in the progression of renal disease. 163
Heparanase is a key player in renal fibrosis by regulating TGF-β expression and activity. 163
Heparanase: A Potential New Factor Involved in the Renal Epithelial Mesenchymal Transition (EMT) Induced by Ischemia/Reperfusion (I/R) Injury. 163
Unusual renal presentation of Fabry disease in a female patient. 162
How safe are organs from deceased donors with neoplasia? The results of the Italian Transplantation Network 162
Directional dominance on stature and cognition in diverse human populations. 160
A comparative kinetic RT/-PCR strategy for the quantitation of mRNAs in microdissected human renal biopsy specimens. 160
ENDOTHELIAL PROGENITOR CELLS IN ACUTE RENAL INJURY 159
Sphingomyelin and medullary sponge kidney disease: a biological link identified by omics approach 158
Genome analyses of >200,000 individuals identify 58 loci for chronic inflammation and highlight pathways that link inflammation and complex disorders 156
Medullary sponge kidney (Lenarduzzi-Cacchi-Ricci disease): A Padua Medical School discovery in the 1930s. 154
Impact of renal replacement therapies on olfactory ability: results of a cross-sectional case control study 154
Sulodexide alone or in combination with low doses of everolimus inhibits the hypoxia-mediated epithelial to mesenchymal transition in human renal proximal tubular cells. 153
Early small creatinine shift predicts contrast-induced acute kidney injury and persistent renal damage after percutaneous coronary procedures 152
Hypomethylation of NLRP3 gene promoter discriminates glucocorticoid-resistant from glucocorticoid-sensitive idiopathic nephrotic syndrome patients 152
Genetic associations at 53 loci highlight cell types and biological pathways relevant for kidney function. 151
A diagnostic-therapeutic pathway for patients with kidney stone disease: 2020 update 151
[Hyponatremia: practical approach to diagnosis and treatment] 150
Heparanase regulates the M1 polarization of renal macrophages and their crosstalk with renal epithelial tubular cells after ischemia/reperfusion injury 149
A London experience 1995-2012: demographic, dietary and biochemical characteristics of a large adult cohort of patients with renal stone disease 149
Heparanase as a target in cancer therapy. 147
Heparanase and syndecan-1 interplay orchestrates fibroblast growth factor-2-induced epithelial-mesenchymal transition in renal tubular cells. 147
Precocious activation of genes of the renin-angiotensin system and the fibrogenic cascade in IgA glomerulonephritis. 146
Dialysis-related transcriptomic profiling: The pivotal role of heparanase. 146
Glycosaminoglycans, proteoglycans and sulodexide and the endothelium: biological roles and pharmacological effects. 146
Modulation of miR-204 expression during chondrogenesis 146
New non-renal congenital disorders associated with medullary sponge kidney (MSK) support the pathogenic role of GDNF and point to the diagnosis of MSK in recurrent stone formers. 145
Bone Disease in Medullary Sponge Kidney and Effect of Potassium Citrate Treatment. 144
Whole-genome sequencing coupled to imputation discovers genetic signals for anthropometric traits 144
Invecchiamento e funzionalità renale: indagine prospettica in una coorte di soggetti anziani in buone condizioni di salute 143
Henoch-Schonlein purpura and Crohn's disease in a family. 142
General practitioners' serum creatinine recording styles. 142
The Genetics of Kidney Stones 142
[Gout and kidney during XVII and XIX centuries] 141
The role of glycosaminoglycans and sulodexide in the treatment of diabetic nephropathy. 141
Randall's plaque, calcium-sensing receptor, and idiopathic calcium nephrolithiasis 141
A STARD-compliant prediction model for diagnosing thrombotic microangiopathies 141
The Role of prEoperative ultraSonography on patenCy of native arteriovenoUs accEss: RESCUE Study (in press) 140
Hyperchloremia and acute kidney injury: a retrospective observational cohort study on a general mixed medical-surgical not ICU-hospitalized population 140
Economic Evaluation of Ferric Carboxymaltose for the Management of Hemodialysis Patients with Iron Deficiency Anemia in Italy 139
Heparanase: another renal player controlled by vitamin d. 138
Involvement of heparanase in the pathogenesis of acute kidney injury: nephroprotective effect of PG545. 138
[PHYSICAL, CHEMICAL AND MORPHOLOGICAL URINE EXAMINATION: RECOMMENDATIONS FOR THE POST ANALYTICAL PHASE FROM THE INTERDISCIPLINARY URINALYSIS GROUP (GIAU)] 138
Improved imputation of low-frequency and rare variants using the UK10K haplotype reference panel. 137
A combination of infrared spectroscopy and morphological analysis allows successfully identifying rare crystals and atypical urinary stones 137
Impact of early glomerular filtration rate decline in response to antihypertensive treatment on risk of end-stage kidney disease and cardiovascular outcomes: a systematic review and meta-analysis 137
LIVER-KIDNEY-TRANSPLANTATION IN TYPE 1 PRIMARY HYPEROXALURIA: DESCRIPTION AND COMMENTS ON A CASE. 136
Discovered cancers at postmortem donor examination: A starting point for quality improvement of donor assessment 136
Artificial intelligence applications for pre-implantation kidney biopsy pathology practice: a systematic review 135
[Uric acid nephrolithiasis] 135
Atypical hemolytic uremic syndrome: Unique clinical presentation linked to rare CFHR5 mutation 134
Proteomic Analysis of Urinary Extracellular Vesicles Reveals a Role for the Complement System in Medullary Sponge Kidney Disease 134
Primary IgA nephropathy is more severe in TGF-ss1 high secretor patients 133
Randall’s plaques, stones familiarity and lithiasic events number: are they associated? 132
[Nutritional diet therapy in the management of the patient with Chronic Kidney Disease in advanced phase to delay the beginning and reduce the frequency of dialysis. An option also in the pre-emptive transplant program] 132
Diagnostic accuracy of a reagent strip for assessing urinary albumin excretion in the general population. 131
Inhibition of heparanase protects against chronic kidney dysfunction following ischemia/reperfusion injury. 131
Totale 16.709
Categoria #
all - tutte 190.831
article - articoli 179.371
book - libri 0
conference - conferenze 5.549
curatela - curatele 0
other - altro 123
patent - brevetti 0
selected - selezionate 0
volume - volumi 5.788
Totale 381.662


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.101 0 498 12 194 75 27 38 187 107 113 138 712
2022/20234.960 494 381 676 609 536 1.278 27 277 445 30 138 69
2023/20242.874 105 226 247 232 277 404 73 559 27 90 386 248
2024/20257.903 481 577 277 1.295 324 190 354 442 1.181 514 594 1.674
2025/202622.782 1.620 1.391 1.919 3.865 4.977 1.364 1.968 1.343 1.716 1.398 474 747
2026/2027406 335 71 0 0 0 0 0 0 0 0 0 0
Totale 50.126